Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- PMID: 31067393
- DOI: 10.1056/NEJMc1902837
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Comment in
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.N Engl J Med. 2019 May 9;380(19):1881-1882. doi: 10.1056/NEJMc1902837. N Engl J Med. 2019. PMID: 31067395 No abstract available.
Comment on
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415602 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical